Title Page
1
Supplement to THE AMERICAN JOURNAL of MEDICINE Ò September 2013 Volume 126 Number 9A Changing Patterns in the Treatment of Type 2 Diabetes GUEST EDITOR Richard E. Pratley, MD Medical Director Florida Hospital Diabetes Institute Orlando, Florida This supplement was published by Elsevier. Development of this supplement was funded by Novo Nordisk and editorial support was provided by Watermeadow Medical. The sponsor provided conceptual direction and editorial assistance, and was also involved in reviewing draft manuscripts for medical accuracy. The authors made all final decisions on the content of the articles and take full responsibility for their accuracy. Statement of Peer Review: All supplement manuscripts submitted to The American Journal of Medicine for publication are reviewed by the Guest Editor(s) of the supplement, by an outside peer reviewer who is independent of the supplement project, and by the Journal’ s Supplement Editor (who ensures that questions raised in peer review have been addressed appropriately and that the supplement has an educational focus that is of interest to our readership). Author Disclosure Policy: All authors contributing to supplements in The American Journal of Medicine are required to fully disclose any primary financial relationship with a company that has a direct fiscal or financial interest in the subject matter or products discussed in the submitted manuscripts, or with a company that produces a competing product. These relationships (eg, ownership of stock or significant honoraria or consulting fees) and any direct support of research by a commercial company must be indicated on the title page of each manuscript. This information will be published in the frontmatter of each supplement.
Transcript of Title Page
Supplement to
THE AMERICANJOURNAL ofMEDICINE �
September 2013
Volume 126
Number 9A
Changing Patterns in the Treatmentof Type 2 Diabetes
GUEST EDITOR
Richard E. Pratley, MDMedical Director
Florida Hospital Diabetes InstituteOrlando, Florida
This supplement was published by Elsevier. Development of this supplement was funded by Novo Nordisk and editorialsupport was provided by Watermeadow Medical.The sponsor provided conceptual direction and editorial assistance, and was also involved in reviewing draft manuscripts formedical accuracy. The authors made all final decisions on the content of the articles and take full responsibility for theiraccuracy.
Statement of Peer Review: All supplement manuscripts submitted to The American Journal of Medicine for publication are
reviewed by the Guest Editor(s) of the supplement, by an outside peer reviewer who is independent of the supplement project,and by the Journal’s Supplement Editor (who ensures that questions raised in peer review have been addressed appropriatelyand that the supplement has an educational focus that is of interest to our readership).Author Disclosure Policy: All authors contributing to supplements in The American Journal of Medicine are required to fullydisclose any primary financial relationship with a company that has a direct fiscal or financial interest in the subject matter orproducts discussed in the submitted manuscripts, or with a company that produces a competing product. These relationships(eg, ownership of stock or significant honoraria or consulting fees) and any direct support of research by a commercialcompany must be indicated on the title page of each manuscript. This information will be published in the frontmatter of eachsupplement.
